title: FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
authors.affiliation: From the Food and Drug Administration, Silver Spring, MD.
authors.forename: Hylton V
authors.initials: HV
authors.lastname: Joffe
authors.forename: Christina
authors.initials: C
authors.lastname: Chang
authors.forename: Catherine
authors.initials: C
authors.lastname: Sewell
authors.forename: Olivia
authors.initials: O
authors.lastname: Easley
authors.forename: Christine
authors.initials: C
authors.lastname: Nguyen
authors.forename: Somya
authors.initials: S
authors.lastname: Dunn
authors.forename: Kimberly
authors.initials: K
authors.lastname: Lehrfeld
authors.forename: LaiMing
authors.initials: L
authors.lastname: Lee
authors.forename: Myong-Jin
authors.initials: MJ
authors.lastname: Kim
authors.forename: Ashley F
authors.initials: AF
authors.lastname: Slagle
authors.forename: Julie
authors.initials: J
authors.lastname: Beitz
mesh_terms: D026683:Advisory Committees; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D004347:Drug Interactions; D005260:Female; D006801:Humans; D017697:Premenopause; D018490:Serotonin Agents / Q000009:adverse effects / Q000627:therapeutic use*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001562:Benzimidazoles; D018490:Serotonin Agents; C098107:flibanserin